Rubicon Research to acquire common stock in Neuronasal

29 Oct 2025 Evaluate

Rubicon Research has entered into a definitive agreement with Neuronasal, Inc., to acquire Common Stock in tranches, for a total consideration of up to $2.5 million. The transaction is a minority investment in Neuronasal Inc. relating to the development of pharmaceutical products.

Rubicon Research is a pharmaceutical formulations company, driven by innovation through focused research and development, with an increasing portfolio of speciality products and drug-device combination products targeting regulated markets and in particular the United States.

Rubicon Research Share Price

678.80 -3.75 (-0.55%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Wework India Managem 609.40
Rubicon Research 678.80
Aegis Vopak Terminal 216.90
Mallcom 1058.10
Inducto Steel 50.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×